Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| casodex prostate |
|
Black Triangle » Blog Archive » Casodex (Bicalutamide) withdrawn Casodex (Bicalutamide) withdrawn for localised prostate cancer Recent results from a study of Casodex (bicalutamide) in early prostate cancer have shown bicalutamide - Cancer Information (Cancers, Symptoms, Treatment BRAND NAME: Casodex. DRUG CLASS AND MECHANISM: Bicalutamide is an oral medication that is used for treating cancer of the prostate. It belongs to a class of Prostate Cancer Info : education, support, male hormone therapy Prostate cancer info on prostate cancer education, prostate cancer support The most common side effects that occurred during treatment with CASODEX plus Prostate Cancer - Casodex^ 150mg plus Radiotherapy Extends Life New data resulting from the 3rd analysis of the Early Prostate Cancer (EPC) Trial Programme confirm that bicalutamide 150mg improves the chance of survival RESULTS FROM LARGEST EVER PROSTATE CANCER STUDY SHOW ASTRAZENECA'S Evidence from one of the three trials in the bicalutamide (Casodex) 150mg Early Prostate Cancer (EPC) Programme presented at the meeting in Geneva, Casodex, cosudex, (bicalutamide) - anti androgen, prostate cancer Casodex, Cosudex (bicalutamide) information, an anti androgen for prostate cancer provided by AstraZeneca. Bicalutamide (Casodex^) : Cancerbackup On the surface of the prostate cancer cells are proteins called receptors. Casodex has a structure similar to the male sex hormone testosterone. Google Answers: effect of casodex on PSA level in prostate cancer --I spent a good deal of time looking for this study as well: Liebertz Casodex, Kelly WK, Theodoulou M, et. al. High dose Casodex for prostate cancer(PC): IngentaConnect Bicalutamide (Casodex)-induced prostate regression Bicalutamide (Casodex)-induced prostate regression involves increased expression of genes encoding insulin-like growth factor binding proteins - IGFBP-5 IngentaConnect Bicalutamide (Casodex) in the treatment of prostate Bicalutamide (Casodex^) in the treatment of prostate cancer. Author: Fradet, Yves. Source: Expert Review of Anticancer Therapy, Volume 4, Number 1, Prostate Cancer and Prostatic Diseases - Bicalutamide (/`Casodex Bicalutamide ('Casodex') 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind Prostate Cancer and Prostatic Diseases - Bicalutamide (Casodex Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' Casodex Side Effects Casodex Prostate Treatment for Cancer from Canada Casodex Side Effects Casodex Prostate Treatment for Cancer from Canada Aggrenox Casodex. Bicalutamide (Casodex) prostate cancer Your doctor has recommended a medication called Casodex as treatment for your prostate cancer. This page provides extra information about your medicine, A S WALLER et al.: Androgen receptor turnover in prostate by In this model, both dihydrotestosterone and Casodex can effectively transport the androgen receptor protein into the nucleus of prostate cells. Casodex Overview - Prostate Cancer Research Institute Verhelst J, Denis L, Van Vliet P, Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer. Casodex (bicalutamide) - Prostate Cancer Treatment Information for Casodex.net provides information on prostate cancer treatment, disease management and Casodex (bicalutamide), a non-steroidal anti-androgen, Casodex (bicalutamide) - Prostate Cancer Treatment Information for CASODEX 150mg as adjuvant to radiotherapy is an attractive alternative to castration in men with locally advanced prostate cancer reducing the risk of dying |
| casodex prostate |
|
cancer impotence injection penile prostate enlarged prostate test after prostate removal causes of prostate enlargement |